BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 27250836)

  • 1. Reduction of cytosolic phospholipase A2α upregulation delays the onset of symptoms in SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Solomonov Y; Hadad N; Levy R
    J Neuroinflammation; 2016 Jun; 13(1):134. PubMed ID: 27250836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early upregulation of cytosolic phospholipase A
    Malada Edelstein YF; Solomonov Y; Hadad N; Alfahel L; Israelson A; Levy R
    J Neuroinflammation; 2021 Nov; 18(1):274. PubMed ID: 34823547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory role of cytosolic phospholipase A
    Malada-Edelstein YF; Hadad N; Levy R
    J Neuroinflammation; 2017 Feb; 14(1):33. PubMed ID: 28187742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis.
    Graber DJ; Hickey WF; Harris BT
    J Neuroinflammation; 2010 Jan; 7():8. PubMed ID: 20109233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice.
    Chen K; Northington FJ; Martin LJ
    Brain Struct Funct; 2010 Mar; 214(2-3):219-34. PubMed ID: 19888600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Almer G; Vukosavic S; Romero N; Przedborski S
    J Neurochem; 1999 Jun; 72(6):2415-25. PubMed ID: 10349851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P-Glycoprotein) in endothelial cells of the blood-brain barrier in mutant superoxide dismutase 1-linked amyotrophic lateral sclerosis.
    Qosa H; Lichter J; Sarlo M; Markandaiah SS; McAvoy K; Richard JP; Jablonski MR; Maragakis NJ; Pasinelli P; Trotti D
    Glia; 2016 Aug; 64(8):1298-313. PubMed ID: 27158936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.
    Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE
    Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Chinese prescription Wen-Pi-Tang extract delays disease onset in amyotrophic lateral sclerosis model mice while attenuating the activation of glial cells in the spinal cord.
    Sekiya M; Ichiyanagi T; Ikeshiro Y; Yokozawa T
    Biol Pharm Bull; 2009 Mar; 32(3):382-8. PubMed ID: 19252282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis.
    Ng SK; Higashimori H; Tolman M; Yang Y
    Exp Neurol; 2015 May; 267():115-22. PubMed ID: 25779930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
    Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
    Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An astrocyte regenerative response from vimentin-containing cells in the spinal cord of amyotrophic lateral sclerosis's disease-like transgenic (G93A SOD1) mice.
    Zhou Y; Lu Y; Fang X; Zhang J; Li J; Li S; Deng X; Yu Y; Xu R
    Neurodegener Dis; 2015; 15(1):1-12. PubMed ID: 25591625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cyclooxygenase-2 in reactive glial cells by the CD40 pathway: relevance to amyotrophic lateral sclerosis.
    Okuno T; Nakatsuji Y; Kumanogoh A; Koguchi K; Moriya M; Fujimura H; Kikutani H; Sakoda S
    J Neurochem; 2004 Oct; 91(2):404-12. PubMed ID: 15447673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.
    Battaglia G; Riozzi B; Bucci D; Di Menna L; Molinaro G; Pallottino S; Nicoletti F; Bruno V
    Neurobiol Dis; 2015 Feb; 74():126-36. PubMed ID: 25434487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
    Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
    BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live imaging of amyotrophic lateral sclerosis pathogenesis: disease onset is characterized by marked induction of GFAP in Schwann cells.
    Keller AF; Gravel M; Kriz J
    Glia; 2009 Aug; 57(10):1130-42. PubMed ID: 19115383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and autophagic alteration in brainstem of SOD1-G93A mouse model of ALS.
    An T; Shi P; Duan W; Zhang S; Yuan P; Li Z; Wu D; Xu Z; Li C; Guo Y
    Mol Neurobiol; 2014 Jun; 49(3):1435-48. PubMed ID: 24390572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of Steroid Hormone Receptors in Motor Neurons and Glia Associates with Disease Progression in ALS Mice.
    McLeod VM; Chiam MDF; Lau CL; Rupasinghe TW; Boon WC; Turner BJ
    Endocrinology; 2020 Sep; 161(9):. PubMed ID: 32621747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocyte-derived Jagged-1 mitigates deleterious Notch signaling in amyotrophic lateral sclerosis.
    Nonneman A; Criem N; Lewandowski SA; Nuyts R; Thal DR; Pfrieger FW; Ravits J; Van Damme P; Zwijsen A; Van Den Bosch L; Robberecht W
    Neurobiol Dis; 2018 Nov; 119():26-40. PubMed ID: 30010003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.